A judge yesterday dismissed most of the claims from pharmacy groups that Express Scripts' (ESRX)...

|About: Express Scripts, Inc. (ESRX)|By:, SA News Editor

A judge yesterday dismissed most of the claims from pharmacy groups that Express Scripts' (ESRX) $29B acquisition of Medco breaches antitrust law. However, the judge allowed the plaintiffs to replead, and said their claims over clinical specialty drugs can move forward.